Analytical Data
-
基因名
SALb
- Application
-
别名
SALb；
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A401R674
-
表达区间
1-864aa
-
氨基酸序列
MSSLFDDSFLADLGPPDEEPPPPPEDEPGPAPEEVPADLFGGRFDAPVSRESYYRDGAARPAIDPAALLEGLNDQQKAAVAHSGGPLLIVAGAGSGKTRVLTHRIAHLLAERHVHPGQILAITFTNKAAGEMKERVEELIGPRANAMWVSTFHSACVRILRRESKRLGFTSSFSIYDAADSKRLMALVCRDLDLDPKRFPPKSFSAKVSNLKNELIDEESFAGTAADGFEKTLSQAYAMYQARLREANALDFDDIIMTTVHLLQAFPDVAEHYRRRFRHVLVDEYQDTNHAQYTLVRELVGPSPTLGSARAGGPPSVDTPAAELCVVGDADQSIYAFRGATIRNILQFEEDYPDATTILLEQNYRSSQTILSAANAVIERNENRRPKNLWTDAGAGPKITGYVADTEHDEAQFVADEIDRLTDAGDAKAGDVAVFYRTNAQSRVFEEIFIRVGLPYKVVGGVRFYERKEVRDILAYLRVLANPEDAVPLRRILNVPKRGIGDRAEAMIEALALREKITFPQALRRVDEAYGMAARSANAVKRFNALMEELRTIVESGAGPATILEAVLERTGYLAELQSSTDPQDETRIENLQELASVALEFEQERGEGAAPAVDARAADAEAGDVEAGDVEAAAAGPGTLAEFLEQVALVADSDQIPDEDEEGAGVITLMTLHTAKGLEFPVVFLTGMEDGVFPHMRALGQTKELEEERRLAYVGITRARERLYVTRSTMRSAWGQPSYNPASRFLEEIPDSFLEWKRTGPATPSASMGGLSSGGSSGGGFGGGIGASLSSTRSKGPSGFATRRTADRPVVSLAVGDRVTHDSFGLGTVVGVKGSGDNAEATIDFGGEKPKRLLLRYAPVEKL
-
分子量
93.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SALb recombinant protein, derived from the Salivary Antigen-Like protein family, has garnered significant attention in biomedical research due to its potential applications in vaccine development and disease prevention. As emerging pathogens and antimicrobial resistance challenge public health, there is an urgent need for innovative therapeutic strategies. The SALb protein exhibits immunogenic properties, suggesting that it may stimulate robust immune responses. This characteristic positions it as a candidate for incorporation into subunit vaccines aimed at enhancing immunity against infectious diseases. In addition, research has indicated that SALb may play a role in modulating host immune responses, which could be pivotal in understanding pathogen-host interactions. Furthermore, as part of ongoing efforts to develop targeted treatments, SALb's role in immune evasion mechanisms employed by certain pathogens is being investigated, offering insights into how such mechanisms may be circumvented. The exploration of SALb recombinant protein thus represents a convergence of interest in immunology, molecular biology, and therapeutic innovation, highlighting its potential to contribute significantly to the field of infectious disease management and vaccine research. The growing body of evidence surrounding SALb underscores the importance of continued research to elucidate its mechanisms of action and optimize its application in medical science.
